{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-113883","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-10-06T11:15:30+00:00","discovered_at":"2026-10-06T11:20:00.385848+00:00","generated_at":"2026-10-12T16:36:54.766064+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Indivior supplements merger proxy after Supernus stockholder suits; Cantor DCF values Indivior $24.20-$43.90","bullets":["Supernus stockholders sent demand letters and filed two complaints in NY Supreme Court alleging the joint proxy/prospectus omitted material disclosure; Supernus denies merit but supplements.","Cantor DCF reference range: Supernus $50.55-$59.50/share (9.5%-11.5% discount rate); Indivior $24.20-$43.90 dividend-adjusted (8.0%-10.0%).","Merger: Artemis Merger Sub merges into Supernus, which survives as a wholly owned Indivior subsidiary; Indivior renamed Supernus, Inc. Special stockholder votes set for October 15, 2026.","Indivior valued with ~$249M cash, ~$500M debt and a $1 billion Special Dividend; Supernus with ~$372M cash and $0 debt, using July 28, 2026 management data.","Terminal growth assumptions range from -10.0% to +3.0% after Dec 31, 2040; fully diluted Indivior share count 124.0M-139.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-113883","json":"https://secwatch.observer/filing/0001104659-26-113883.json","markdown":"https://secwatch.observer/filing/0001104659-26-113883.md","text":"https://secwatch.observer/filing/0001104659-26-113883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000110465926113883/0001104659-26-113883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000110465926113883/tm2627060d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:36:54.766064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}